IQVIA Holdings Inc. (NYSE:IQV) Shares Sold by Gulf International Bank UK Ltd

Gulf International Bank UK Ltd lowered its position in shares of IQVIA Holdings Inc. (NYSE:IQV) by 27.5% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 14,659 shares of the medical research company’s stock after selling 5,562 shares during the quarter. Gulf International Bank UK Ltd’s holdings in IQVIA were worth $3,473,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. First Foundation Advisors increased its stake in shares of IQVIA by 3.8% in the 2nd quarter. First Foundation Advisors now owns 1,161 shares of the medical research company’s stock valued at $245,000 after purchasing an additional 43 shares in the last quarter. Team Hewins LLC increased its stake in IQVIA by 5.0% during the 1st quarter. Team Hewins LLC now owns 973 shares of the medical research company’s stock worth $246,000 after buying an additional 46 shares in the last quarter. Invera Wealth Advisors LLC increased its stake in IQVIA by 0.3% during the 2nd quarter. Invera Wealth Advisors LLC now owns 14,506 shares of the medical research company’s stock worth $3,183,000 after buying an additional 46 shares in the last quarter. Covestor Ltd increased its stake in IQVIA by 45.3% during the 1st quarter. Covestor Ltd now owns 154 shares of the medical research company’s stock worth $39,000 after buying an additional 48 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund increased its stake in IQVIA by 0.3% during the 2nd quarter. Oregon Public Employees Retirement Fund now owns 15,668 shares of the medical research company’s stock worth $3,313,000 after buying an additional 48 shares in the last quarter. Institutional investors and hedge funds own 89.62% of the company’s stock.

Analyst Upgrades and Downgrades

IQV has been the subject of several research reports. TD Cowen cut their price objective on IQVIA from $270.00 to $255.00 and set a “buy” rating for the company in a research note on Friday, November 1st. StockNews.com upgraded IQVIA from a “hold” rating to a “buy” rating in a research report on Wednesday, October 30th. BTIG Research dropped their price target on IQVIA from $290.00 to $260.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Evercore ISI dropped their price target on IQVIA from $270.00 to $265.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Finally, JPMorgan Chase & Co. decreased their price objective on IQVIA from $279.00 to $240.00 and set an “overweight” rating on the stock in a report on Tuesday. Four research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $259.13.

IQVIA Stock Up 1.3 %

NYSE:IQV opened at $212.96 on Wednesday. The stock has a market capitalization of $38.65 billion, a price-to-earnings ratio of 27.95, a price-to-earnings-growth ratio of 2.07 and a beta of 1.51. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 1.76. IQVIA Holdings Inc. has a 52 week low of $190.20 and a 52 week high of $261.73. The stock’s fifty day moving average is $232.84 and its two-hundred day moving average is $229.54.

Insider Activity

In other news, insider Eric Sherbet sold 1,300 shares of the stock in a transaction on Tuesday, August 27th. The stock was sold at an average price of $246.33, for a total value of $320,229.00. Following the sale, the insider now directly owns 19,536 shares in the company, valued at approximately $4,812,302.88. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.60% of the company’s stock.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.